6.
Shigemura N, Sclabassi R, Bhama J, Gries C, Crespo M, Johnson B
. Early major neurologic complications after lung transplantation: incidence, risk factors, and outcome. Transplantation. 2013; 95(6):866-71.
DOI: 10.1097/TP.0b013e318280b359.
View
7.
Rosenberger E, Dew M, DiMartini A, DeVito Dabbs A, Yusen R
. Psychosocial issues facing lung transplant candidates, recipients and family caregivers. Thorac Surg Clin. 2012; 22(4):517-29.
PMC: 3516399.
DOI: 10.1016/j.thorsurg.2012.08.001.
View
8.
Scragg P, Jones A, Fauvel N
. Psychological problems following ICU treatment. Anaesthesia. 2001; 56(1):9-14.
DOI: 10.1046/j.1365-2044.2001.01714.x.
View
9.
Timofte I, Terrin M, Barr E, Sanchez P, Kim J, Reed R
. Belatacept for renal rescue in lung transplant patients. Transpl Int. 2015; 29(4):453-63.
DOI: 10.1111/tri.12731.
View
10.
Khush K, Cherikh W, Chambers D, Harhay M, Hayes Jr D, Hsich E
. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match. J Heart Lung Transplant. 2019; 38(10):1056-1066.
PMC: 6816343.
DOI: 10.1016/j.healun.2019.08.004.
View
11.
Brazis P, Spivey J, Bolling J, Steers J
. A case of bilateral optic neuropathy in a patient on tacrolimus (FK506) therapy after liver transplantation. Am J Ophthalmol. 2000; 129(4):536-8.
DOI: 10.1016/s0002-9394(99)00443-2.
View
12.
Lake D, Poole T
. Tacrolimus. Br J Ophthalmol. 2002; 87(1):121-2.
PMC: 1771477.
DOI: 10.1136/bjo.87.1.121.
View
13.
Bloom R, Reese P
. Chronic kidney disease after nonrenal solid-organ transplantation. J Am Soc Nephrol. 2007; 18(12):3031-41.
DOI: 10.1681/ASN.2007040394.
View
14.
Shutter L, Green J, Newman N, Hooks M, Gordon R
. Cortical blindness and white matter lesions in a patient receiving FK506 after liver transplantation. Neurology. 1993; 43(11):2417-8.
DOI: 10.1212/wnl.43.11.2417.
View
15.
Reilly M, Plappert T, Wiegers S
. Cerebrovascular emboli related to pulmonary venous thrombosis after lung transplantation. J Am Soc Echocardiogr. 1998; 11(3):299-302.
DOI: 10.1016/s0894-7317(98)70093-8.
View
16.
Li Y, Gottlieb J, Ma D, Kuehn C, Strueber M, Welte T
. Graft-protective effects of the HMG-CoA reductase inhibitor pravastatin after lung transplantation--a propensity score analysis with 23 years of follow-up. Transplantation. 2011; 92(4):486-92.
DOI: 10.1097/TP.0b013e318225670d.
View
17.
OBrien S, Carton E, Fealy G
. Long-Term Health-Related Quality of Life After Venovenous Extracorporeal Membrane Oxygenation. ASAIO J. 2019; 66(5):580-585.
DOI: 10.1097/MAT.0000000000001042.
View
18.
Anderson B, Chesley C, Theodore M, Christie C, Tino R, Wysoczanski A
. Incidence, risk factors, and clinical implications of post-operative delirium in lung transplant recipients. J Heart Lung Transplant. 2018; 37(6):755-762.
PMC: 5970008.
DOI: 10.1016/j.healun.2018.01.1295.
View
19.
Goetzmann L, Ruegg L, Stamm M, Ambuhl P, Boehler A, Halter J
. Psychosocial profiles after transplantation: a 24-month follow-up of heart, lung, liver, kidney and allogeneic bone-marrow patients. Transplantation. 2008; 86(5):662-8.
DOI: 10.1097/TP.0b013e3181817dd7.
View
20.
Chambers D, Cherikh W, Harhay M, Hayes Jr D, Hsich E, Khush K
. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipient size match. J Heart Lung Transplant. 2019; 38(10):1042-1055.
PMC: 6816340.
DOI: 10.1016/j.healun.2019.08.001.
View